SELLAS Life Sciences Group, Inc. (SLS)
5.53
+0.25
(+4.73%)
USD |
NASDAQ |
Mar 06, 16:00
5.41
-0.12
(-2.17%)
After-Hours: 05:07
SELLAS Life Sciences Group SG&A Expense (TTM) : 11.21M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 383.49M |
| Vanda Pharmaceuticals, Inc. | 237.95M |
| GT Biopharma, Inc. | 4.731M |
| ADMA Biologics, Inc. | 96.42M |
| Lyell Immunopharma, Inc. | 49.04M |